Description: Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.
Home Page: www.enzo.com
21 Executive Blvd
Farmingdale,
NY
11735
United States
Phone:
631 755 5500
Officers
| Name | Title |
|---|---|
| Ms. Kara Cannon | CEO & Director |
| Ms. Patricia Eckert CPA | Chief Financial Officer |
| Mr. Brian J. Fisher | General Counsel & Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.956 |
| Price-to-Sales TTM: | 1.6199 |
| IPO Date: | |
| Fiscal Year End: | July |
| Full Time Employees: | 125 |